Alto Neuroscience, Inc. (ANRO) Free cash flow 2023–2025
Alto Neuroscience, Inc. (ANRO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$51.8MFY2025 · since FY2023: -$33.9M → -$51.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.8M | -4.6% |
| FY2024 | -$49.5M | -45.9% |
| FY2023 | -$33.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANRO financial trends
ANRO RevenueANRO Net incomeANRO Net marginANRO Gross profitANRO Gross marginANRO Operating incomeANRO Operating marginANRO Operating cash flowANRO Capital expendituresANRO Return on equityANRO Stock buybacksANRO Dividends paidANRO Total assetsANRO Total liabilitiesANRO Shareholders’ equityANRO overview →